✦ LIBER ✦

Clinical and Microbiologic Analysis of a Hospital's Extended-Spectrum β-Lactamase-Producing Isolates Over a 2-Year Period

✍ Scribed by Dr. David S. Burgess; Dr. Ronald G. Hall II; Dr. James S. Lewis II; Dr. James H. Jorgensen; Dr. Jan E. Patterson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence of extended-spectrum β-lactam

✍ C. Varela; A. Oliver; T. M. Coque; F. Baquero; R. Cantón 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB

Epidemiology of Escherichia coli clinica

✍ Stéphane Corvec; Lise Crémet; Céline Leprince; Sandie Dauvergne; Alain Reynaud; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Molecular epidemiology of extended-spect

✍ Peirano, G.; Hung King Sang, J.; Pitondo-Silva, A.; Laupland, K. B.; Pitout, J. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 261 KB

Surveillance of extended-spectrum β-lact

✍ A. Kola; M. Holst; I.F. Chaberny; S. Ziesing; S. Suerbaum; P. Gastmeier 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Prevalence of extended spectrum β-lactam

✍ Prachi K. Dandekar; Janice Tetreault; John P. Quinn; Charles H. Nightingale; Dav 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Activity of tigecycline against clinical

✍ A. Sorlózano; J. Gutiérrez; A. Salmerón; J.D. Luna; F. Martínez-Checa; J. Román; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 164 KB